What kind of immune response does the body mount in response to common medications?
Author：
Source：
Release time：2023-05-20
Summary： Recently, a research report published in the international journal Nature Immunology detailed how scientists from institutions including Monash University in Australia have, through their studies, shed light on the body’s immune responsiveness to commonly used drugs. While many medications are effective in treating diseases, they can also give rise to harmful side effects; moreover, it is well known that some drugs may even impair the functioning of the immune system.
Recently, a research report published in the international journal Nature Immunology detailed how scientists from institutions including Monash University in Australia have elucidated the immune‑mediated susceptibility of the organism to commonly used drugs. While many medications effectively treat disease, they can also give rise to adverse side effects. It is well known that some drugs may exert unpredictable effects on immune system function, yet the underlying mechanisms remain poorly understood.
In this study, researchers investigated which drugs can activate a specific type of immune cell—MAIT cells, which are mucosal-associated invariant T cells. They found that certain medications can suppress MAIT cells’ ability to detect infections, while others may trigger undesirable immune responses. These findings could help researchers understand why some individuals mount immune reactions to particular drugs and also offer new avenues for developing strategies to modulate MAIT cell function in patients with specific diseases.
Researcher Andrew Keller stated that T cells are a crucial component of the human immune system, capable of safeguarding health by detecting signs of cellular infection and activating the immune response to defend against foreign invaders. In this study, the researchers employed computational models to predict the potential effects of chemical structures, drugs, and drug-like molecules on MAIT cells, including certain small-molecule compounds such as salicylates, nonsteroidal anti-inflammatory drugs (e.g., diclofenac), and drug metabolites.
Researchers suggest that this study may shed light on the potential link between the heightened sensitivity of known drugs and MAIT cells. Moreover, gaining a deeper understanding of the interactions between MAIT cells and other host cells could help scientists better predict and mitigate the risks associated with developing therapies that might compromise health.
Finally, the researchers stated that this study also offers promising prospects for the development of novel therapies in the future. They hope to devise innovative treatments that modulate MAIT cell behavior, thereby enhancing or suppressing the host immune response to achieve clinically beneficial outcomes for patients.
Keywords:
Body,Medicine,Immunity
Related News
Inquiry
If you are interested in our information, please leave your contact details, and we will get in touch with you as soon as possible. Thank you!
Consultation Phone Number
Headquarters Address
Suzhou Industrial Park, Suzhou City, Jiangsu Province
Room 302, Building B, No. 388 Ruoshui Road
Copyright © 2026 Changyi Guangke (Suzhou) Technology Co., Ltd.